Chao Qi
About
Chao Qi is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases.
According to data from OpenAlex, Chao Qi has authored 161 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 51 papers in Epidemiology and 41 papers in Infectious Diseases. Recurrent topics in Chao Qi's work include Bacterial Identification and Susceptibility Testing (27 papers), Antibiotic Resistance in Bacteria (26 papers) and Peroxisome Proliferator-Activated Receptors (26 papers). Chao Qi is often cited by papers focused on Bacterial Identification and Susceptibility Testing (27 papers), Antibiotic Resistance in Bacteria (26 papers) and Peroxisome Proliferator-Activated Receptors (26 papers). Chao Qi collaborates with scholars based in United States, China and Singapore. Chao Qi's co-authors include Janardan K. Reddy, Mahendra S. Rao, Yijun Zhu, Anjana V. Yeldandi, Marc H. Scheetz, Michael Malczynski, Teresa Zembower, Takashi Hashimoto, Sanjay Jain and William S. Cook and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
In The Last Decade
Chao Qi
156 papers receiving 6.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chao Qi United States | 45 | 3.6k | 1.5k | 1.1k | 764 | 733 | 161 | 6.5k | ||
| John W. Christman United States | 58 | 3.2k 0.9× | 1.4k 0.9× | 1.3k 1.2× | 297 0.4× | 1.5k 2.0× | 201 | 10.6k | ||
| Christian Jobin United States | 48 | 5.1k 1.4× | 1.2k 0.9× | 914 0.8× | 691 0.9× | 1.6k 2.2× | 85 | 9.7k | ||
| Paal Skytt Andersen Denmark | 48 | 3.4k 1.0× | 1.3k 0.9× | 317 0.3× | 1.0k 1.3× | 211 0.3× | 186 | 8.2k | ||
| Michel Chignard France | 56 | 2.4k 0.7× | 2.0k 1.3× | 1.2k 1.1× | 263 0.3× | 835 1.1× | 187 | 10.3k | ||
| Robert C. Cooksey United States | 47 | 2.7k 0.7× | 2.1k 1.5× | 1.3k 1.2× | 355 0.5× | 276 0.4× | 109 | 7.3k | ||
| Bin Wang China | 42 | 3.7k 1.0× | 633 0.4× | 328 0.3× | 746 1.0× | 879 1.2× | 217 | 7.1k | ||
| Christian Jobin United States | 53 | 6.4k 1.8× | 883 0.6× | 1.0k 0.9× | 304 0.4× | 818 1.1× | 160 | 10.2k | ||
| Christopher Carpenter United States | 20 | 2.4k 0.7× | 1.1k 0.8× | 182 0.2× | 463 0.6× | 298 0.4× | 51 | 6.6k | ||
| Mark D. Wewers United States | 57 | 4.9k 1.4× | 1.8k 1.2× | 1.0k 0.9× | 85 0.1× | 980 1.3× | 178 | 11.4k | ||
| Qiao Yang China | 27 | 1.6k 0.4× | 1.3k 0.9× | 419 0.4× | 269 0.4× | 206 0.3× | 214 | 5.4k |
Countries citing papers authored by Chao Qi
Since
Specialization
Citations
This map shows the geographic impact of Chao Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Qi more than expected).
Fields of papers citing papers by Chao Qi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chao Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Qi. The network helps show where Chao Qi may publish in the future.
Co-authorship network of co-authors of Chao Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Chao Qi. A scholar is included among the top collaborators of Chao Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Qi. Chao Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Qi, Chao, et al.. (2024). Heart-brain interactions: clinical evidence and mechanisms based on critical care medicine. Frontiers in Cardiovascular Medicine. 11. 1483482–1483482.
2.
Weber, Rachel Palmieri, Sajal D. Tanna, Valentina Stosor, et al.. (2024). Mycobacteroides abscessus outbreak and mitigation in a cardiothoracic transplant population: the problem with tap water. Journal of Hospital Infection. 155. 150–157.
3.
Zheng, Debin, Yinghao Ding, Jingfei Liu, et al.. (2024). Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy. Advanced Science. 11(28). e2401327–e2401327.
4.
Achenbach, Chad J., Claudia Hawkins, Lauren C. Balmert, et al.. (2022). Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection. PLoS ONE. 17(6). e0270060–e0270060.
5.
Rhodes, Nathaniel J., Paul R. Yarnold, Anna Pawlowski, et al.. (2022). Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 67(1). e0102322–e0102322.
6.
Bulman, Zackery P., Fiorella Krapp, Nathan B. Pincus, et al.. (2021). Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae. mSystems. 6(5). e0019421–e0019421.
7.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Teresa Zembower, et al.. (2021). Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study. International Journal of Antimicrobial Agents. 59(2). 106490–106490.
8.
Li, Tianyi, Junduo Wu, Jia Liu, et al.. (2021). Protocol for the Acute Myocardial Infarction Study in Northeastern China (AMINoC): a real-world prospective cohort study. BMJ Open. 11(5). e042936–e042936.
9.
Pickens, Chiagozie I., Catherine A. Gao, Michael J. Cuttica, et al.. (2021). Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. American Journal of Respiratory and Critical Care Medicine. 204(8). 921–932.
10.
Chen, Zhenzhen, Youyou Yan, Junduo Wu, et al.. (2020). Expression level and diagnostic value of exosomal NEAT1 /miR ‐204/MMP ‐9 in acute ST ‐segment elevation myocardial infarction. IUBMB Life. 72(11). 2499–2507.
11.
Qi, Chao, Chiagozie I. Pickens, James M. Walter, et al.. (2019). Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing. Journal of Medical Microbiology. 68(7). 996–1002.
12.
Liu, Lulu, Bin Liu, Jiajun Ren, et al.. (2018). Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 18(1). 46–46.
13.
Esterly, John S., et al.. (2017). Use of organism identification by 16S ribosomal RNA polymerase chain reaction to shorten antimicrobial length of therapy. Diagnostic Microbiology and Infectious Disease. 88(2). 163–167.
14.
Zembower, Teresa, et al.. (2015). Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species. American Journal of Respiratory and Critical Care Medicine. 191(11). 1310–1317.
15.
Zhang, Zijing, Xiuge Wang, Rongling Li, et al.. (2015). Genetic mutations potentially cause two novel NCF1 splice variants up-regulated in the mammary gland, blood and neutrophil of cows infected by Escherichia coli. Microbiological Research. 174. 24–32.
16.
Ju, Zhihua, Xue Zheng, Jinming Huang, et al.. (2012). Functional Characterization of Genetic Polymorphisms Identified in the Promoter Region of the Bovine PEPS Gene. DNA and Cell Biology. 31(6). 1038–1045.
17.
Esterly, John S., Jamie L. Wagner, Milena M. McLaughlin, et al.. (2012). Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification. Antimicrobial Agents and Chemotherapy. 56(9). 4885–4890.
18.
Zhu, Yiwei Tony, et al.. (2009). PRIP Promotes Tumor Formation through Enhancing Serum-responsive Factor-mediated FOS Expression. Journal of Biological Chemistry. 284(21). 14485–14492.
19.
Hu, Liping, Yiwei Tony Zhu, Chao Qi, & Yi-Jun Zhu. (2009). Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development. Cancer Research. 69(9). 4067–4072.
20.
Qi, Chao, Papreddy Kashireddy, Yiwei Tony Zhu, Sambasiva M. Rao, & Yi-Jun Zhu. (2004). Null Mutation of Peroxisome Proliferator-activated Receptor-interacting Protein in Mammary Glands Causes Defective Mammopoiesis. Journal of Biological Chemistry. 279(32). 33696–33701.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by John W. Christman Breakdown of academic impact, for papers by Christian Jobin Breakdown of academic impact, for papers by Paal Skytt Andersen Breakdown of academic impact, for papers by Michel Chignard Breakdown of academic impact, for papers by Robert C. Cooksey Breakdown of academic impact, for papers by Bin Wang Breakdown of academic impact, for papers by Christian Jobin Breakdown of academic impact, for papers by Christopher Carpenter Breakdown of academic impact, for papers by Mark D. Wewers Breakdown of academic impact, for papers by Qiao Yang